A patient who is taking phenytoin suspension (Dilantin-125) has ...

[theo]

A patient who is taking phenytoin suspension (Dilantin-125) has been given instructions on its use. Which statement accurately describes the correct way to administer the drug?
 
  a. Mix the liquid in food.
  b. Add the liquid to another beverage.
  c. Shake the container before use.
  d. Never shake the container before use.

Question 2

A patient with a history of seizure disorder is taking mephobarbital (Mebaral) as part of drug therapy for the disorder. Which of the following laboratory tests should be used to monitor for adverse drug effects?
 
  a. Complete blood count (CBC)
  b. Uric acid level
  c. Salicylate level
  d. Electrolytes

[Tonny]

Answer to Question 1

ANS: C
Dilantin suspension must be well shaken before use. If this is not done, a subtherapeutic dose will be obtained from the top of the container, and a dose above the therapeutic range will be ob-tained from the bottom of the container.

Answer to Question 2

ANS: A
Mephobarbital can cause agranulocytosis, thrombocytopenia, and megaloblastic anemia. A CBC would detect these adverse drug effects.

[theo]

Gracias!

[cdmart10]

Thanks for the timely response, appreciate it